Cutaneous manifestations associated with malignancy of the head and neck

被引:2
作者
Lorimer, Patrick [1 ]
Milas, Zvonimir [1 ]
机构
[1] Carolinas HealthCare Syst, Levine Canc Inst, Dept Surg Oncol, Charlotte, NC 28204 USA
关键词
Head and neck skin cancer; Basal cell carcinoma; Squamous cell carcinoma; Merkel cell carcinoma; MERKEL-CELL-CARCINOMA; MOHS MICROGRAPHIC SURGERY; BASAL-CELL; SEBACEOUS CARCINOMA; EXCISION MARGINS; IN-SITU; ANGIOSARCOMA; MELANOMA; MANAGEMENT; EPIDEMIOLOGY;
D O I
10.1053/j.seminoncol.2016.02.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Most cutaneous malignancies of the head and neck (HN) are non-melanoma skin cancers, predominantly basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs). Less common entities include Merkel cell carcinoma (MCC), sebaceous carcinoma (SC), and angiosarcoma. Treatment is based on histology subtype, stage, and extent of involvement. Surgery is the primary means of treatment and includes wide local excision, Mohs micrographic surgery, sentinel lymph node biopsy, and cervical lymphadenectomy. Multidisciplinary management including radiation and targeted chemotherapy are critical adjuncts to surgery. Surgical planning must balance oncologic, functional, and cosmetic considerations. This review addresses cutaneous manifestations of primary malignancies of the HN and dermatologic complications of small molecule inhibitors used for targeted therapy. A working knowledge of both the cutaneous malignancies (CM) in the head and neck as well as the secondary dermatologic manifestations is relevant to multiple disciplines including dermatology, medical oncology, radiation oncology, and surgical oncology. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:353 / 358
页数:6
相关论文
共 58 条
[1]   Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007 [J].
Albores-Saavedra, Jorge ;
Schwartz, Arnold M. ;
Henson, Donald E. ;
Kostun, Lara ;
Hart, Alexandra ;
Angeles-Albores, David ;
Chable-Montero, Fredy .
ANNALS OF DIAGNOSTIC PATHOLOGY, 2011, 15 (02) :93-97
[2]   Treatment of Advanced Cutaneous Squamous Cell Carcinomas with Epidermal Growth Factor Receptor Inhibitors [J].
Alter, M. ;
Satzger, I. ;
Mattern, A. ;
Kapp, A. ;
Gutzmer, R. .
DERMATOLOGY, 2013, 227 (04) :289-294
[3]  
[Anonymous], 2010, AJCC CANC STAGING MA
[4]   Advanced Treatment for Basal Cell Carcinomas [J].
Atwood, Scott X. ;
Whitson, Ramon J. ;
Oro, Anthony E. .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2014, 4 (07)
[5]   Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas [J].
Balch, CM ;
Soong, S ;
Smith, T ;
Ross, MI ;
Urist, MM ;
Karakousis, CP ;
Temple, WJ ;
Mihm, MC ;
Barnhill, RL ;
Jewell, WR ;
Wanebo, HJ ;
Desmond, R .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (02) :101-108
[6]   Basal cell carcinoma in young women: An evaluation of the association of tanning bed use and smoking [J].
Boyd, AS ;
Shyr, Y ;
King, LE .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (05) :706-709
[7]   Angiosarcoma Outcomes and Prognostic Factors A 25-Year Single Institution Experience [J].
Buehler, Darya ;
Rice, Stephanie R. ;
Moody, John S. ;
Rush, Patrick ;
Hafez, Gholam-Reza ;
Attia, Steven ;
Longley, B. Jack ;
Kozak, Kevin R. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (05) :473-479
[8]   Is There Truly No Benefit with Sunscreen Use and Basal Cell Carcinoma? A Critical Review of the Literature and the Application of New Sunscreen Labeling Rules to Real-World Sunscreen Practices [J].
Chesnut, Cameron ;
Kim, Jenny .
JOURNAL OF SKIN CANCER, 2012, 2012
[9]   Basal Cell Carcinoma: An Evidence-Based Treatment Update [J].
Clark, Charlotte M. ;
Furniss, Megan ;
Mackay-Wiggan, Julian M. .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2014, 15 (03) :197-216
[10]   Guidelines for management of Bowen's disease: 2006 update [J].
Cox, N. H. ;
Eedy, D. J. ;
Morton, C. A. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (01) :11-21